The role focuses on leading the Go-to-Market strategy for a critical mRNA reagent portfolio essential for drug and vaccine manufacturing.
Base: $101,700 - $188,900; Bonus/Equity: Discretionary annual bonus available; Benefits: Standard company benefits package included
Must-have
Nice-to-have
Not specified